Ripride Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 66.27%
- Ebitda 66.27%
- Net Worth -2.65%
- Total Assets 6.56%
About Ripride Remedies
Ripride Remedies Private Limited (RRPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 January 2018 (Seven years 6 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajnish Chordia, Ankit Chordia, and Akshat Chordia serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24304MP2018PTC044963
- Company No.
044963
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2018
- Date of AGM
12 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Ripride Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshat Chordia  | Director | 24-Jan-2018 | Current |
| Rajnish Chordia | Director | 20-Jan-2020 | Current |
| Ankit Chordia | Director | 24-Jan-2018 | Current |
Financial Performance of Ripride Remedies.
Ripride Remedies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 66.27% increase in profit. The company's net worth dipped by a decrease of 2.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ripride Remedies?
Unlock access to Ripride Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rini Life Science Private LimitedRajnish Chordia is a mutual person
Kriti Exim LlpRajnish Chordia is a mutual person
- Sanndesh Infra Builders Private Limited
Rajnish Chordia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ripride Remedies?
Unlock and access historical data on people associated with Ripride Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ripride Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ripride Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.